The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy

Bibliographic Details
Title: The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy
Authors: Haoran E, Junqi Wu, Yijiu Ren, Lang Xia, Long Xu, Shaoling Li, Yue Zhao, Chongwu Li, Yunlang She, Chunxia Su, Chunyan Wu, Likun Hou, Deping Zhao, Chang Chen
Source: Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Publisher Information: SAGE Publishing, 2023.
Publication Year: 2023
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Background: Grading system for resected invasive pulmonary adenocarcinoma proposed by the International Association for the Study of Lung Cancer (IASLC) was validated as a strong prognostic indicator. Nonetheless, the efficacy of utilizing such grading system in prognostic assessment of patients receiving neoadjuvant therapy still needs elucidating. Methods: A retrospective study was conducted including patients with resected adenocarcinoma following neoadjuvant chemotherapy or targeted therapy from August 2012 to December 2020 in Shanghai Pulmonary Hospital. All the surgical specimens were re-evaluated and graded. The prognostic value of the grading system was further validated. Results: Ultimately, a total of 198 patients were enrolled in this study, and subdivided into three cohorts according to the grading system. There were 13 (6.6%), 37 (18.7%), and 148 (74.7%) patients belonging to Grades 1, 2, and 3, respectively. IASLC grading system demonstrated significant power in prognosis differentiation of the entire cohort [recurrence-free survival (RFS), p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1758-8359
17588359
Relation: https://doaj.org/toc/1758-8359
DOI: 10.1177/17588359221148028
Access URL: https://doaj.org/article/af4640557a184f0d878db0b6e68642fe
Accession Number: edsdoj.f4640557a184f0d878db0b6e68642fe
Database: Directory of Open Access Journals
More Details
ISSN:17588359
DOI:10.1177/17588359221148028
Published in:Therapeutic Advances in Medical Oncology
Language:English